Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer

Langenbeck's Archives of Surgery
Antonios-Apostolos K TentesThespis Dimitriou

Abstract

D2 gastrectomy has improved survival in gastric cancer. Adjuvant intravenous chemotherapy, radiotherapy, or multimodal therapy has failed to demonstrate improved survival. The results of intraarterial chemotherapy (IARC) as an adjuvant have been encouraging in a few studies. A prospective randomized trial was designed to evaluate the toxicity and survival in locally advanced gastric cancer using IARC as an adjuvant after potentially curative gastrectomy. Forty patients with locally advanced gastric cancer were randomly selected to undergo either potentially curative gastrectomy and receive IARC (study group) or gastrectomy only (control group). Clinical and histopathologic data were analyzed and the toxicity related to IARC was recorded. The groups were comparable (p>0.05). Three patients in the study group had minor toxicity. Five-year survival rate for the study and the control group was 52 and 54%, respectively (p>0.05). Mean survival for the study and the control group was 50+/-8 and 62+/-10 months, respectively (p>0.05). The number of recurrences and the failure sites were comparable (p>0.05). Intraarterial chemotherapy can be safely applied to gastric cancer patients. As proposed by the protocol, the method cannot be reco...Continue Reading

References

Aug 1, 1987·World Journal of Surgery·K MaruyamaT Kinoshita
Oct 1, 1995·Japanese Journal of Cancer Research : Gann·A M NomuraP H Chyou
Jan 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J WilsH Wilke
Nov 17, 1993·Journal of the National Cancer Institute·J A AjaniD A Vena
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J HermansC J Van de Velde
Dec 11, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·K H LinkH G Beger
Aug 19, 1999·The European Journal of Surgery = Acta Chirurgica·J D HowellC S McArdle
Mar 22, 2002·The Lancet Oncology·N Kemeny, F Fata
Apr 16, 2002·Seminars in Oncology·William D Ensminger
Dec 19, 2002·Scandinavian Journal of Urology and Nephrology·Sadamu TsukamotoShinji Sugahara
Apr 8, 2003·Annals of Surgical Oncology·Alejandro SierraJavier A-Cienfuegos
Apr 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H H HartgrinkM Sasako
May 13, 2004·British Journal of Cancer·P EdwardsD R B Jones
Jul 17, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H H HartgrinkUNKNOWN Cooperating Investigators of The Dutch Gastric Cancer Group
May 17, 2005·Journal of Surgical Oncology·John S Macdonald

❮ Previous
Next ❯

Citations

Dec 19, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Wen-Tao ShiJing-Wei Zhang
Sep 4, 2013·The Cochrane Database of Systematic Reviews·Rafael Diaz-NietoMarc Winslet
Jan 16, 2019·Cancers·Tom van den EndeHanneke W M van Laarhoven

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
N Muñoz
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Melissa M CenterElizabeth Ward
© 2021 Meta ULC. All rights reserved